Bioventix (BVXP) Competitors GBX 2,272 -53.00 (-2.28%) As of 11:27 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock BVXP vs. SLN, PRTC, HZD, AVCT, VRP, FARN, ARIX, CIR, TILS, and VSNShould you be buying Bioventix stock or one of its competitors? The main competitors of Bioventix include Silence Therapeutics (SLN), PureTech Health (PRTC), Horizon Discovery Group plc (HZD.L) (HZD), Avacta Group (AVCT), Verona Pharma plc (VRP.L) (VRP), Faron Pharmaceuticals Oy (FARN), Arix Bioscience (ARIX), Circassia Group (CIR), Tiziana Life Sciences (TILS), and Verseon (VSN). These companies are all part of the "biotechnology" industry. Bioventix vs. Its Competitors Silence Therapeutics PureTech Health Horizon Discovery Group plc (HZD.L) Avacta Group Verona Pharma plc (VRP.L) Faron Pharmaceuticals Oy Arix Bioscience Circassia Group Tiziana Life Sciences Verseon Silence Therapeutics (LON:SLN) and Bioventix (LON:BVXP) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk and dividends. Which has better valuation & earnings, SLN or BVXP? Bioventix has higher revenue and earnings than Silence Therapeutics. Silence Therapeutics is trading at a lower price-to-earnings ratio than Bioventix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSilence Therapeutics£11.35M0.00N/A-£48.60N/ABioventix£13.66M8.69£8.12M£148.1215.34 Do institutionals & insiders believe in SLN or BVXP? 32.4% of Bioventix shares are held by institutional investors. 6.1% of Bioventix shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media refer more to SLN or BVXP? In the previous week, Bioventix had 1 more articles in the media than Silence Therapeutics. MarketBeat recorded 1 mentions for Bioventix and 0 mentions for Silence Therapeutics. Bioventix's average media sentiment score of 0.67 beat Silence Therapeutics' score of 0.00 indicating that Bioventix is being referred to more favorably in the news media. Company Overall Sentiment Silence Therapeutics Neutral Bioventix Positive Is SLN or BVXP more profitable? Bioventix has a net margin of 59.51% compared to Silence Therapeutics' net margin of 0.00%. Bioventix's return on equity of 69.09% beat Silence Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Silence TherapeuticsN/A N/A N/A Bioventix 59.51%69.09%54.07% SummaryBioventix beats Silence Therapeutics on 10 of the 10 factors compared between the two stocks. Get Bioventix News Delivered to You Automatically Sign up to receive the latest news and ratings for BVXP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BVXP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BVXP vs. The Competition Export to ExcelMetricBioventixBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£124.09M£219.08M£6.15B£2.66BDividend Yield6.61%3.81%5.71%5.35%P/E Ratio15.343.2429.72400.58Price / Sales8.695,399.10499.2198,316.49Price / Cash30.8913.1936.6127.90Price / Book9.8890.1012.017.26Net Income£8.12M-£90.99M£3.32B£5.88B7 Day Performance-6.89%0.30%1.54%1.12%1 Month Performance-7.45%3.84%6.10%1.37%1 Year Performance-36.85%555.79%61.10%117.34% Bioventix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BVXPBioventixN/AGBX 2,272-2.3%N/A-36.0%£124.09M£13.66M15.3412Gap DownSLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading VolumePRTCPureTech HealthN/AGBX 131.90+0.8%GBX 455+245.0%-14.6%£318.78M£6.17M775.88300HZDHorizon Discovery Group plc (HZD.L)N/AN/AN/AN/A£302.98M£54.63M-33.55416AVCTAvacta Group1.9268 of 5 starsGBX 70.21+2.5%GBX 99+41.0%+10.3%£286.65M£113K-400.07120VRPVerona Pharma plc (VRP.L)N/AN/AN/AN/A£228MN/A-1.6822Gap UpFARNFaron Pharmaceuticals OyN/AGBX 173.11-1.1%N/A-4.8%£193.81MN/A-641.1534Positive NewsHigh Trading VolumeARIXArix BioscienceN/AN/AN/AN/A£183.73M£14.16M1,290.919CIRCircassia GroupN/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap DownTILSTiziana Life SciencesN/AN/AN/AN/A£113.85M-£3.60M-3.5911VSNVerseonN/AN/AN/AN/A£112.24MN/A-5.17N/AGap Up Related Companies and Tools Related Companies Silence Therapeutics Competitors PureTech Health Competitors Horizon Discovery Group plc (HZD.L) Competitors Avacta Group Competitors Verona Pharma plc (VRP.L) Competitors Faron Pharmaceuticals Oy Competitors Arix Bioscience Competitors Circassia Group Competitors Tiziana Life Sciences Competitors Verseon Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:BVXP) was last updated on 10/24/2025 by MarketBeat.com Staff From Our PartnersWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredWhat Wall Street Won’t Say Out LoudDiscover the 7 key indicators before everyone else doesAmerican Alternative | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioventix PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioventix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
